Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals

Graphical Abstract This note examines three aspects of antivirals as they can potentially relate to the treatment of COVID-19; (i) the use of vaporization for the delivery of antivirals, with the bulk constituents having mild antiviral efficacy, (ii) a counter intuitive approach to formulation that, is in part, based on delivering multiple species that fall into three categories; building blocks for the virus to accelerate replication; an energy source for the infected cell to boast its immune response; species that antagonize or provide toxicity to the virus, (iii) the application of a marine natural product extract with several species, as opposed to a focusing on a single molecule as the anti-viral agent.

• Publication year

  2020

• Venue

  Drug Discovery Today

• Publication date

  2020-04-20

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.drudis.2020.04.010PMID 32325124PMCID 7169894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surveillance and taxonomic analysis of the coronavirus dominant in pigeons in China

  2020cited by this paper
• Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know

  2020cited by this paper
• Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

  2020cited by this paper
• Novel pathways of HIV latency reactivation revealed by integrated analysis of transcriptome and target profile of bryostatin

  2020cited by this paper
• Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication

  2019cited by this paper
• Bryostatin 1 alleviates respiratory syncytial virus pneumonia in a mice model via down-regulation of inflammatory cytokines

  2019cited by this paper
• Neuro-regeneration Therapeutic for Alzheimer's Dementia: Perspectives on Neurotrophic Activity.

  2019cited by this paper
• A Copper10-Paclitaxel crystal; a medicinally active drug delivery platform.

  2018cited by this paper
• Particle Size Dynamics: Toward a Better Understanding of Electronic Cigarette Aerosol Interactions With the Respiratory System

  2018cited by this paper
• Effects of electronic cigarette liquid solvents propylene glycol and vegetable glycerin on user nicotine delivery, heart rate, subjective effects, and puff topography.

  2018cited by this paper
• Cell line studies and analytical measurements of three paclitaxel complex variations.

  2017cited by this paper
• Pharmacokinetic studies of a three-component complex that repurposes the front line antibiotic isoniazid against Mycobacterium tuberculosis.

  2017cited by this paper
• Drug Vaping: From the Dangers of Misuse to New Therapeutic Devices

  2016cited by this paper
• Isolation, analytical measurements, and cell line studies of the iron-bryostatin-1 complex.

  2016cited by this paper
• Marine natural products: Bryostatins in preclinical and clinical studies

  2014cited by this paper
• Structural and some medicinal characteristics of the copper(II)-hydroxychloroquine complex.

  2013cited by this paper
• Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner

  2010cited by this paper
• Identification of a Novel Coronavirus from a Beluga Whale by Using a Panviral Microarray

  2008cited by this paper
• Evolutionary Relationships of “Candidatus Endobugula” Bacterial Symbionts and Their Bugula Bryozoan Hosts

  2008cited by this paper
• Isolation and characterization of a novel protein toxin from fire coral.

  2008cited by this paper
• Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer

  2008cited by this paper
• Impact of environmental conditions on the marine natural product bryostatin 1

  2006cited by this paper
• Effect of ammonium chloride on the multiplication of infectious pancreatic necrosis virus

  2005cited by this paper
• Identifying bryostatins and potential precursors from the bryozoan Bugula neritina

  2005cited by this paper
• Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritina.

  2004cited by this paper
• Isolation and structure of bryostatin 1

  1982cited by this paper

• Ethanol Inhalation as a Method to Denature the Spike Protein of SARS-CoV-2.

  2024cites this paper
• Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease

  2024cites this paper
• Facile Synthesis of Substituted Pyrroles Using Silica Supported Catalysis

  2023cites this paper
• Therapeutic potential of pyrrole and pyrrolidine analogs: an update

  2022cites this paper
• A Three-Component Solvent for the Treatment for COVID-19: Is the Data in Place for Clinical Trial?

  2021cites this paper
• Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease

  2021cites this paper
• Should ethanol be considered a treatment for COVID-19?

  2020cites this paper
• Drug repurposing: new strategies for addressing COVID-19 outbreak

  2020cites this paper